Nektar Therapeutics | 流动资产



金融业
股票价格
USD
资产
USD 301.35M
现金及等价物
USD 41.03M
销售成本
USD 4.44M
流动资产
USD 281.36M
流动负债
USD 66.34M
债务
USD 0
股息收益率
0
EBIT
USD -34.35M
EBITDA
USD -31.81M
员工
137
EPS每股收益
USD -0.18
股本和储备
USD 85.09M
销售毛利
USD 13.75M
债务利息支出
USD 6.02M
利息收入
USD -0.18
贷款资金
USD 107.51M
市值
USD 9.53B
净收入
USD -37.06M
营业费用
USD 85.09M
营业利润
USD -34.35M
普通股股本
USD 19K
税前利润
USD -37.05M
销售收入
USD 24.12M
销售和管理费用
USD -0.18
股票
USD 14.46M
贸易债权人
USD 15.56M
应收帐款人
USD 0


流动资产 更改 日
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
ALKERMES USD 1.74B 106.38M 2025-09
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amgen USD 29.06B 1.17B 2025-12
Baxter International USD 6.93B 184M 2025-09
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Cipla INR 249.18B 16.3B 2025-09
Dr.Reddys Laboratories INR 297.55B 18.03B 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 62.07B 12.22B 2025-09
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Exelixis USD 1.44B 41.03M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.16B 409.5M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Takeda JPY 3.12T 195.82B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xencor USD 518.44M 5.29M 2025-09


Nektar Therapeutics 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.